{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T10:14:42Z","timestamp":1720952082451},"reference-count":27,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Ther Med"],"DOI":"10.3892\/etm.2019.7988","type":"journal-article","created":{"date-parts":[[2019,9,9]],"date-time":"2019-09-09T07:13:22Z","timestamp":1568013202000},"source":"Crossref","is-referenced-by-count":4,"title":["Factors affecting the therapeutic effect of botulinum toxin A on trigeminal neuralgia: A follow\u2011up retrospective study of 152 patients"],"prefix":"10.3892","author":[{"given":"Haifeng","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yajun","family":"Lian","sequence":"additional","affiliation":[{"name":"Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nanchang","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuan","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongliang","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yake","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2019,9,9]]},"reference":[{"key":"key20200713101112_b1-etm-0-0-7988","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1136\/jnnp.2003.031286","article-title":"The International classification of headache disorders, 2nd edn (ICDH-II)","volume":"75","author":"Olesen","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key20200713101112_b2-etm-0-0-7988","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1002\/ana.410270114","article-title":"Incidence and clinical features of trigeminal neuralgia, Rochester, Minnesota, 1945\u20131984","volume":"27","author":"Katusic","year":"1990","journal-title":"Ann Neurol"},{"key":"key20200713101112_b3-etm-0-0-7988","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1016\/j.tripleo.2009.03.021","article-title":"Injection of botulinum toxin type A (BOTOX) into trigger zone of trigeminal neuralgia as a means to control pain","volume":"109","author":"Ngeow","year":"2010","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"key20200713101112_b4-etm-0-0-7988","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1097\/00002508-200201000-00002","article-title":"Pathophysiology of trigeminal neuralgia: The ignition hypothesis","volume":"18","author":"Devor","year":"2002","journal-title":"Clin J Pain"},{"key":"key20200713101112_b5-etm-0-0-7988","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1586\/14737175.7.11.1565","article-title":"Trigeminal neuralgia: For one nerve a multitude of treatments","volume":"7","author":"Cheshire","year":"2007","journal-title":"Expert Rev Neurother"},{"key":"key20200713101112_b6-etm-0-0-7988","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1136\/bmj.327.7428.1360","article-title":"Treatment options for trigeminal neuralgia","volume":"327","author":"Merrison","year":"2003","journal-title":"BMJ"},{"key":"key20200713101112_b7-etm-0-0-7988","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.medcli.2016.07.032","article-title":"Botulinum toxin in trigeminal neuralgia","volume":"148","author":"Castillo-Alvarez","year":"2017","journal-title":"Med Clin (Barc)"},{"key":"key20200713101112_b8-etm-0-0-7988","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/S0300-9084(00)00216-9","article-title":"How botulinum and tetanus neurotoxins block neurotransmitter release","volume":"82","author":"Humeau","year":"2000","journal-title":"Biochimie"},{"key":"key20200713101112_b9-etm-0-0-7988","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/S0041-0101(96)00180-8","article-title":"Pharmacologic characterization of botulinum toxin for basic science and medicine","volume":"35","author":"Pearce","year":"1997","journal-title":"Toxicon"},{"key":"key20200713101112_b10-etm-0-0-7988","first-page":"3","article-title":"Treatment of 795 facial spasm and local dystonia with Botulinum toxin A","volume":"44","author":"Lian","year":"2009","journal-title":"J Zhengzhou Univ (Med Sci)"},{"key":"key20200713101112_b11-etm-0-0-7988","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1111\/j.1526-4610.2011.01990.x","article-title":"OnabotulinumtoxinA for treatment of chronic migraine: Pooled analyses of the 56-week PREEMPT clinical program","volume":"51","author":"Aurora","year":"2011","journal-title":"Headache"},{"key":"key20200713101112_b12-etm-0-0-7988","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1177\/0333102410364677","article-title":"OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial","volume":"30","author":"Diener","year":"2010","journal-title":"Cephalalgia"},{"key":"key20200713101112_b13-etm-0-0-7988","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1097\/00002826-200209000-00006","article-title":"Beneficial effects of botulinum toxin type a for patients with painful tic convulsif","volume":"25","author":"Micheli","year":"2002","journal-title":"Clin Neuropharmacol"},{"key":"key20200713101112_b14-etm-0-0-7988","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1177\/0333102412441721","article-title":"Botulinum toxin type A for the treatment of trigeminal neuralgia: Results from a randomized, double-blind, placebo-controlled trial","volume":"32","author":"Wu","year":"2012","journal-title":"Cephalalgia"},{"key":"key20200713101112_b15-etm-0-0-7988","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/1129-2377-14-72","article-title":"Therapeutic efficacy and safety of botulinum toxin type A in trigeminal neuralgia: A systematic review","volume":"14","author":"Hu","year":"2013","journal-title":"J Headache Pain"},{"key":"key20200713101112_b16-etm-0-0-7988","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s10194-016-0651-8","article-title":"Therapeutic efficacy and safety of botulinum toxin a therapy in trigeminal neuralgia: A systematic review and meta-analysis of randomized controlled trials","volume":"17","author":"Morra","year":"2016","journal-title":"J Headache Pain"},{"key":"key20200713101112_b17-etm-0-0-7988","first-page":"S9","article-title":"The International Classification of Headache Disorders: 2nd edition","volume":"24","author":"Headache Classification Subcommittee of the International Headache Society","year":"2004","journal-title":"Cephalalgia"},{"key":"key20200713101112_b18-etm-0-0-7988","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1046\/j.1035-6851.2001.00230.x","article-title":"Pain measurement: Understanding existing tools and their application in the emergency department","volume":"13","author":"Lee","year":"2001","journal-title":"Emerg Med (Fremantle)"},{"key":"key20200713101112_b19-etm-0-0-7988","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1080\/10618600.1996.10474713","article-title":"R: A language for data analysis and graphics","volume":"5","author":"Ross","year":"1996","journal-title":"J Computational Graphical Statistics"},{"key":"key20200713101112_b20-etm-0-0-7988","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1177\/0333102412459577","article-title":"Botulinum toxin type A for trigeminal neuralgia-we have the prima facie evidence","volume":"32","author":"Zakrzewska","year":"2012","journal-title":"Cephalalgia"},{"key":"key20200713101112_b21-etm-0-0-7988","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/1129-2377-15-65","article-title":"Two doses of botulinum toxin type A for the treatment of trigeminal neuralgia: Observation of therapeutic effect from a randomized, double-blind, placebo-controlled trial","volume":"15","author":"Zhang","year":"2014","journal-title":"J Headache Pain"},{"key":"key20200713101112_b22-etm-0-0-7988","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1129-2377-15-43","article-title":"Therapeutic effect of botulinum toxin-a in 88 patients with trigeminal neuralgia with 14-month follow-up","volume":"15","author":"Li","year":"2014","journal-title":"J Headache Pain"},{"key":"key20200713101112_b23-etm-0-0-7988","first-page":"2","article-title":"Effect of botulinum toxin type a on clssic trigeminal neuralgia","volume":"26","author":"Shen","year":"2011","journal-title":"Chin J Rehab Med"},{"key":"key20200713101112_b24-etm-0-0-7988","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1097\/AJP.0b013e31827eafff","article-title":"Subcutaneous and perineural botulinum toxin type A for neuropathic pain: A descriptive review","volume":"29","author":"Fabregat","year":"2013","journal-title":"Clin J Pain"},{"key":"key20200713101112_b25-etm-0-0-7988","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1097\/00042728-200403000-00030","article-title":"The therapeutic potential of botulinum toxin","volume":"30","author":"Klein","year":"2004","journal-title":"Dermatologic Surgery"},{"key":"key20200713101112_b26-etm-0-0-7988","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.neuro.2005.01.017","article-title":"Review of a proposed mechanism for the antinociceptive action of botulinum toxin type A","volume":"26","author":"Aoki","year":"2005","journal-title":"Neurotoxicology"},{"key":"key20200713101112_b27-etm-0-0-7988","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.pain.2008.10.005","article-title":"Subcutaneous Botulinum toxin type A reduces capsaicin-induced trigeminal pain and vasomotor reactions in human skin","volume":"141","author":"Gazerani","year":"2009","journal-title":"Pain"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"deposited":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T09:11:16Z","timestamp":1594631476000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/etm.2019.7988"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,9]]},"references-count":27,"URL":"https:\/\/doi.org\/10.3892\/etm.2019.7988","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,9]]}}}